Caltagirone SpA (CALT)
Sep 20, 2024 - CALT was voluntarily delisted
40.00
-0.04 (-0.10%)
Inactive · Last trade price
on Sep 20, 2024
Company Description
Caltagirone SpA, through its subsidiaries, engages in the cement manufacturing, media, real estate, and publishing activities.
It is involved the publication of Italian newspapers, internet content, and social press; cement, aggregates, concrete, and value-added products; and leasing, sale, enhancement, management, and maintenance of building apartments in residential areas.
The company also build projects, such as Fiera di Milano Rho-Pero, the Rome-Naples high-speed railway line and Line C.
The company was founded in 1892 and is based in Rome, Italy. Caltagirone SpA is a subsidiary of Finanziaria Italia 2005 SpA.
Caltagirone SpA
Country | Italy |
Founded | 1892 |
IPO Date | Jun 5, 2020 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 3,749 |
CEO | Renee Aguiar-Lucander |
Contact Details
Address: Via Barberini 28 Rome, 00187 Italy | |
Phone | 39 06 45 41 22 00 |
Website | caltagironespa.it |
Stock Details
Ticker Symbol | CALT |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | EUR |
IPO Price | $19.50 |
CIK Code | 0001795579 |
CUSIP Number | 13124Q106 |
ISIN Number | US13124Q1067 |
SIC Code | 3241 |
Key Executives
Name | Position |
---|---|
Renee Aguiar-Lucander | Chief Executive Officer |
Fredrik Johansson | Chief Financial Officer |
Lars Stubberud | Vice President of Technical Operations |
Asa Hillsten | Head of IR and Sustainability |
Brian Gorman | Group General Counsel |
Sandra Frithiof | Vice President of Human Resources |
Ann-Kristin Myde BSc | Head of Clinical Development and Vice President of Project Management |
Dr. Richard S. Philipson M.D. | Chief Medical Officer |
Teona Johnson | Head of US Marketing |
David Ferraro | Head of US Sales |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Sep 23, 2024 | 15F-12B | Filing |
Sep 23, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
Sep 20, 2024 | 25-NSE | Filing |
Sep 18, 2024 | SC TO-T/A | Filing |
Sep 18, 2024 | SC 14D9/A | Filing |
Sep 17, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
Sep 16, 2024 | EFFECT | Notice of Effectiveness |
Sep 16, 2024 | SC TO-T/A | Filing |
Sep 13, 2024 | 25 | Filing |
Sep 13, 2024 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |